866-997-4948(US-Canada Toll Free)

United States Live Attenuated Vaccine Market Report 2017

Published By :

QYResearch

Published Date : Feb 2017

Category :

Pharmaceutical

No. of Pages : 103 Pages

Notes:
Sales, means the sales volume of Live Attenuated Vaccine
Revenue, means the sales value of Live Attenuated Vaccine

This report studies sales (consumption) of Live Attenuated Vaccine in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Astellas Pharma Inc
CSL Limited
Emergent BioSolutions
GlaxoSmithKline
Johnson&Johnson
MedImmune
Merck
Pfizer
Sanofi Pasteur

Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Split by applications, this report focuses on sales, market share and growth rate of Live Attenuated Vaccine in each application, can be divided into
Application 1
Application 2

Table of Contents

United States Live Attenuated Vaccine Market Report 2017
1 Live Attenuated Vaccine Overview
1.1 Product Overview and Scope of Live Attenuated Vaccine
1.2 Classification of Live Attenuated Vaccine
1.2.1 Type I
1.2.2 Type II
1.3 Application of Live Attenuated Vaccine
1.3.1 Application 1
1.3.2 Application 2
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Live Attenuated Vaccine (2012-2022)
1.4.1 United States Live Attenuated Vaccine Sales and Growth Rate (2012-2022)
1.4.2 United States Live Attenuated Vaccine Revenue and Growth Rate (2012-2022)

2 United States Live Attenuated Vaccine Competition by Manufacturers
2.1 United States Live Attenuated Vaccine Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Live Attenuated Vaccine Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Live Attenuated Vaccine Average Price by Manufactures (2015 and 2016)
2.4 Live Attenuated Vaccine Market Competitive Situation and Trends
2.4.1 Live Attenuated Vaccine Market Concentration Rate
2.4.2 Live Attenuated Vaccine Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Live Attenuated Vaccine Sales (Volume) and Revenue (Value) by States (2012-2017)
3.1 United States Live Attenuated Vaccine Sales and Market Share by States (2012-2017)
3.2 United States Live Attenuated Vaccine Revenue and Market Share by States (2012-2017)
3.3 United States Live Attenuated Vaccine Price by States (2012-2017)

4 United States Live Attenuated Vaccine Sales (Volume) and Revenue (Value) by Type (2012-2017)
4.1 United States Live Attenuated Vaccine Sales and Market Share by Type (2012-2017)
4.2 United States Live Attenuated Vaccine Revenue and Market Share by Type (2012-2017)
4.3 United States Live Attenuated Vaccine Price by Type (2012-2017)
4.4 United States Live Attenuated Vaccine Sales Growth Rate by Type (2012-2017)

5 United States Live Attenuated Vaccine Sales (Volume) by Application (2012-2017)
5.1 United States Live Attenuated Vaccine Sales and Market Share by Application (2012-2017)
5.2 United States Live Attenuated Vaccine Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Live Attenuated Vaccine Manufacturers Profiles/Analysis
6.1 Astellas Pharma Inc
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Live Attenuated Vaccine Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Astellas Pharma Inc Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 CSL Limited
6.2.2 Live Attenuated Vaccine Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 CSL Limited Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Emergent BioSolutions
6.3.2 Live Attenuated Vaccine Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Emergent BioSolutions Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 GlaxoSmithKline
6.4.2 Live Attenuated Vaccine Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 GlaxoSmithKline Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Johnson&Johnson
6.5.2 Live Attenuated Vaccine Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Johnson&Johnson Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 MedImmune
6.6.2 Live Attenuated Vaccine Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 MedImmune Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Merck
6.7.2 Live Attenuated Vaccine Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Merck Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Pfizer
6.8.2 Live Attenuated Vaccine Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Pfizer Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Sanofi Pasteur
6.9.2 Live Attenuated Vaccine Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Sanofi Pasteur Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview

7 Live Attenuated Vaccine Manufacturing Cost Analysis
7.1 Live Attenuated Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Live Attenuated Vaccine

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Live Attenuated Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Live Attenuated Vaccine Major Manufacturers in 2015
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Live Attenuated Vaccine Market Forecast (2017-2022)
11.1 United States Live Attenuated Vaccine Sales, Revenue Forecast (2017-2022)
11.2 United States Live Attenuated Vaccine Sales Forecast by Type (2017-2022)
11.3 United States Live Attenuated Vaccine Sales Forecast by Application (2017-2022)
11.4 Live Attenuated Vaccine Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix
Methodology
Analyst Introduction
Data Source

List of Table

List of Tables and Figures

Figure Picture of Live Attenuated Vaccine
Table Classification of Live Attenuated Vaccine
Figure United States Sales Market Share of Live Attenuated Vaccine by Type in 2015
Table Application of Live Attenuated Vaccine
Figure United States Sales Market Share of Live Attenuated Vaccine by Application in 2015
Figure United States Live Attenuated Vaccine Sales and Growth Rate (2012-2022)
Figure United States Live Attenuated Vaccine Revenue and Growth Rate (2012-2022)
Table United States Live Attenuated Vaccine Sales of Key Manufacturers (2015 and 2016)
Table United States Live Attenuated Vaccine Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Live Attenuated Vaccine Sales Share by Manufacturers
Figure 2016 Live Attenuated Vaccine Sales Share by Manufacturers
Table United States Live Attenuated Vaccine Revenue by Manufacturers (2015 and 2016)
Table United States Live Attenuated Vaccine Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Live Attenuated Vaccine Revenue Share by Manufacturers
Table 2016 United States Live Attenuated Vaccine Revenue Share by Manufacturers
Table United States Market Live Attenuated Vaccine Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Live Attenuated Vaccine Average Price of Key Manufacturers in 2015
Figure Live Attenuated Vaccine Market Share of Top 3 Manufacturers
Figure Live Attenuated Vaccine Market Share of Top 5 Manufacturers
Table United States Live Attenuated Vaccine Sales by States (2012-2017)
Table United States Live Attenuated Vaccine Sales Share by States (2012-2017)
Figure United States Live Attenuated Vaccine Sales Market Share by States in 2015
Table United States Live Attenuated Vaccine Revenue and Market Share by States (2012-2017)
Table United States Live Attenuated Vaccine Revenue Share by States (2012-2017)
Figure Revenue Market Share of Live Attenuated Vaccine by States (2012-2017)
Table United States Live Attenuated Vaccine Price by States (2012-2017)
Table United States Live Attenuated Vaccine Sales by Type (2012-2017)
Table United States Live Attenuated Vaccine Sales Share by Type (2012-2017)
Figure United States Live Attenuated Vaccine Sales Market Share by Type in 2015
Table United States Live Attenuated Vaccine Revenue and Market Share by Type (2012-2017)
Table United States Live Attenuated Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Live Attenuated Vaccine by Type (2012-2017)
Table United States Live Attenuated Vaccine Price by Type (2012-2017)
Figure United States Live Attenuated Vaccine Sales Growth Rate by Type (2012-2017)
Table United States Live Attenuated Vaccine Sales by Application (2012-2017)
Table United States Live Attenuated Vaccine Sales Market Share by Application (2012-2017)
Figure United States Live Attenuated Vaccine Sales Market Share by Application in 2015
Table United States Live Attenuated Vaccine Sales Growth Rate by Application (2012-2017)
Figure United States Live Attenuated Vaccine Sales Growth Rate by Application (2012-2017)
Table Astellas Pharma Inc Basic Information List
Table Astellas Pharma Inc Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Astellas Pharma Inc Live Attenuated Vaccine Sales Market Share (2012-2017)
Table CSL Limited Basic Information List
Table CSL Limited Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table CSL Limited Live Attenuated Vaccine Sales Market Share (2012-2017)
Table Emergent BioSolutions Basic Information List
Table Emergent BioSolutions Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Emergent BioSolutions Live Attenuated Vaccine Sales Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Live Attenuated Vaccine Sales Market Share (2012-2017)
Table Johnson&Johnson Basic Information List
Table Johnson&Johnson Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Johnson&Johnson Live Attenuated Vaccine Sales Market Share (2012-2017)
Table MedImmune Basic Information List
Table MedImmune Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table MedImmune Live Attenuated Vaccine Sales Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Merck Live Attenuated Vaccine Sales Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Live Attenuated Vaccine Sales Market Share (2012-2017)
Table Sanofi Pasteur Basic Information List
Table Sanofi Pasteur Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Sanofi Pasteur Live Attenuated Vaccine Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Live Attenuated Vaccine
Figure Manufacturing Process Analysis of Live Attenuated Vaccine
Figure Live Attenuated Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Live Attenuated Vaccine Major Manufacturers in 2015
Table Major Buyers of Live Attenuated Vaccine
Table Distributors/Traders List
Figure United States Live Attenuated Vaccine Production and Growth Rate Forecast (2017-2022)
Figure United States Live Attenuated Vaccine Revenue and Growth Rate Forecast (2017-2022)
Table United States Live Attenuated Vaccine Production Forecast by Type (2017-2022)
Table United States Live Attenuated Vaccine Consumption Forecast by Application (2017-2022)
Table United States Live Attenuated Vaccine Sales Forecast by States (2017-2022)
Table United States Live Attenuated Vaccine Sales Share Forecast by States (2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *